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1. Introduction
   During last decade there has been an exponential growth 
in use of herbal products for treatment of various types of 
diseases[1]. In general, treatment involving herbal drugs 
spans a long duration of time. In contrast to general old 
age myth that herbal drugs are safe and do not have toxic 
effects, These drugs may cause some moderate to severe 
side effects due to complex nature of their chemical 
compositions. Hence, there is a need to establish safety to 
herbal drugs through validated scientific toxicity studies 
or protocols.
  Clerodendrum inerme (C. inerme), Jasminum mesnyi (J. 
mesnyi) Hance and Callistemon citrinus (C. citrinus) (Figure 
1) are used for treatment of diabetes mellitus in traditional 
system of medicine in India. C. inerme belonging to 
family Verbenacae has been used as antidiabetic agent 
in folklore medicinal system of India. It is reported to 
have antibacterial, hepatoprotective, anticarcinogenic, 
uterine and intestine stimulating properties. The 
various constituents characterised in its leaves include 
phenylethanoid glycoside, neo-clerodane diterpinoids 
antiviral proteins (CIP-29 and CIP-34) and three iridoid 
glucoside (Inerminoside A1, C and D[2-4]. J. mesnyi 
Hance belonging to family Oleaceae is an evergreen 
shrub having bright yellow flowers. It is native of China 
and grown in Indian gardens[5]. The major constituents 
present in this plant include 毬-sitosterol, 毩-amyrin, 
毬-glucoside flavonoids, constituents include rutin and 
secoiridoid glucosides (9-hydroxyjasminoside, 9-hydroxy 
jasminosidic acid, Jasmoside and jasminoside)[6,7]. C. 
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citrinus belonging to family Myrtaceae is woody aromatic 
tree widely distributed in the wet tropics, especially 
Australia, South America and tropical Asia. It is mainly 
used as an ornamental plant. The major constituents 
present in C. citrinus include oxygenated monoterpenes, 
monoterpene hydrocarbons, 1,8 cineole, 毩-pinene, 毬
-pinene, 毩-terpinene and 毩-terpineole. Its leaves 
are employed as substitute of tea to have a delightful 
and refreshing flavor[8,9,10]. However, its medicinal uses 
are not reported widely and its constituents are being 
investigated for herbicidal properties and for potential 
in human medicine. Despite their traditional use in 
treatment of diabetes mellitus, there is no systematic study 
on exploration of antidiabetic potential of these plants. 
Further, diabetes mellitus, being a chronic disease, needs 
a long term treatment and chronic consumption of these 
herbs may cause mild to severe side or toxic effects. 
However, there is no report on toxicity evaluation of these 
plants in literature[11,12]. Hence, the present study has been 
designed to evaluate the acute and sub-acute toxicity 
of different extracts of these plants in order to establish 
therapeutic safety of these herbs.
Figure 1.C. inerme (A), J. mesnyi Hance (B) and C. citrinus (C).    
                                                                                                                                                      
                                                          
2. Methods and materials
  Swiss albino mice (25-30 g) and Wistar albino rats of 
either sex (150-250g) were procured from Lala Lajpat Rai 
University of Veterinary & animal Sciences, Hisar and 
housed in Animal House of Hindu College of Pharmacy 
(Sonepat, India) (Reg No. 585/02/CPCSEA) under controlled 
environmental conditions (25依2) oC with natural light/
dark cycle. The animals were allowed free access to 
food (standard pellet diet, Golden feed, Delhi, India) 
and water and acclimatized for at least a week before 
the commencement of the experiment. All experiments 
were duly approved by the Institutional Animal Ethics 
committee. 
  The leaves of C. inerme, J. mesnyi Hance and C. citrinus 
were collected from healthy plants in Sonipat(India) in 
July 2009. The leaves were authenticated by Dr. H.B. 
Singh (Scientist F and Head Raw Materials Herbarium 
and Museum, NISCAIR, Delhi) with a Voucher number - 
Niscair/RHMD/Consult/-2009-10/1241/45. 
2.1. Chemicals and reagents
  The chemicals and solvents required for chemical 
evaluation and extracts were procured commercially from 
E. Merck (Mumbai, India), s.d. fine chemicals (Mumbai, 
India) and C.D.H. Private Limited, (New Delhi, India). 
Soxhlet extraction assembly of 2 L capacity (Borosil, New 
Delhi, India) was used for extraction of plant material. The 
extracts were concentrated on rotary vacuum evaporator 
(Hi - Con, New Delhi, India)
2.2. Preparation of extracts
 
  The leaves were dried at room temperature under well-
ventilated shade by spreading them uniformly. The 
dried leaves were sorted, powdered, weighed (about 270 
g) and extracted with petroleum ether to remove fatty 
constituents and chlorophyll. The marc was then subjected 
to successive solvent extraction with different solvents viz. 
Ethyl acetate, Chloroform, Ethanol and Water in soxhlet 
apparatus using about 800 mL of each solvent. Each extract 
was dried under vacuum and percent yield was calculated 
as % w/w with respect to total weight of dried leaves taken 
for extraction[13,14].
2.3. Acute toxicity study  
  The acute toxicity studies were carried out on Swiss 
albino mice of either sex weighing 25-30 g by the method 
described by Miller and Tainter[15,16]. The toxicity study 
was conducted at six doses (0.5, 1.0, 2.0, 3.0, 4.0 and 5.0 
g/kg) of each of ethyl acetate, chloroform, ethanolic and 
aqueous extracts of C. inerme, J. mesnyi Hance and C. 
citrinus. The animals were divided into different groups 
with 6 animals in each group and fasted overnight. Each 
extract was administered orally at each of the six dose 
levels. The animals were observed for first 12 h for any 
toxic symptoms and for 24 h for any mortality. The number 
of animals dying during the period was noted. The LD50 
was calculated by the method of Miller and Tainter. The 
percent mortality was calculated followed by calculation of 
the corrected percent mortality using the formula:
For 0% death = 100 伊 (0.25/n)
For 100% death = 100 伊 [(n-0.25)/n]
  Where, n is the number of animals in each group. 
Corrected percent mortality was then transformed into 
probit values[17,18]. A graph of percent mortality (in probits) 
was plotted against log dose. The dose corresponding to 
probit 5 was read to be LD50.
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2.4. Sub-acute toxicity study 
  Healthy Wistar albino rats of either sex weighing (150-
250 g) were divided into different groups with 6 rats in each 
group. The control group received vehicle alone and the 
other groups received maximum therapeutic dose (MTD) of 
ethanolic, aqueous, ethyl acetate and chloroform extracts 
of C. inerme, J. Mesnyi Hance and C. citrinus for 28 d. 
The MTD was calculated from LD50 determined through 
acute toxicity study. The animals were monitored for body 
weight, mortality, food and water intake daily. After 28 
days, all animals were fasted overnight and anaesthetized 
with ether[19,20]. The blood samples were collected 
in heparinised tubes for determining haematological 
parameters such as haemoglobin, RBC count, WBC count, 
blood urea, creatinine, SGOT, SGPT and blood sugar 
level[21,22,23].
2.5. Statistical analysis
  All results were expressed as Mean 依 Standard error. Data 
were analyzed using two-way analysis of variance (ANOVA) 
followed by Tukey’s test. The results were regarded as 
significant at P<0.05.
3.  Results
  The % yield of each extract of each of the selected plants 
is given in Table 1. Ethanol extract of C. inerme was 
obtained with maximum yield (22.8%) whereas chloroform 
extract of C. citrinus was obtained in minimum amount 
(0.1%). 
Table 1. 
Successive extract of leaves of C. inerme (CI), J. mesnyi Hance (JM), 
and C. citrinus (CC)
Extract    
Extract Yield (% w/w of dried plant material)
C. inerme (CI) J. mesnyi Hance (JM) C. citrinus (CC)
Pet. Ether 2.96 4.02 5.32
Ethyl Acetate 3.81 3.75 8.61
Chloroform 2.10 9.81 0.10
Ethanol 22.80 8.61 9.21
Water 10.12 15.2 13.54
3.1. Acute toxicity 
  It was carried out to determine LD50 of each extract of
C. inerme, J. mesnyi Hance and C. citrinus. Each extract 
was found to be non-toxic upto a dose of 2 g/kg in mice. 
The LD50 of each extract is given in Table 2. The 1/5th of 
LD50 of each extract was taken as its MTD for subsequent 
Table 2.
LD50 and MTD of the ethyl acetate (EA), chloroform(C), ethanolic (E) and aqueous (A) extracts of C. inerme (CI), J. Mesnyi Hance (JM) and C. 
citrinus (CC).
Extract LD50 (mg/kg) MTD(mg/kg) Extract LD50 (mg/kg) MTD(mg/kg) Extract LD50 (mg/kg) MTD(mg/kg)
EACI 4 000 800 EAJM 4 000 800 EACC 4 000 800
CCI 3 600 720 CJM 3 500 700 CCC 4 200 840
ECI 3 600 720 EJM 4 000 800 ECC 3 200 640
ACI 4 300 860 AJM 4 800 960 ACC 4 000 800
Table 3.
Haematological and biochemical parameters of animals during sub-acute toxicity study.
S.No. Parameter Clinical Parameter Values expressed as Mean  依 SEM (n=6)
EACI CCI ECI ACI EAJM CJM EJM AJM EACC CCC ECC ACC
1 Body Wt. (g) Pre-treatment 174.00依7.13 176.00依5.85 ECI 169.00依4.60 171.00依9.32 158依6.44 179.00依8.18 181.00依7.27 193.00依9.48 175.00依7.26 175.00依6.34 192依6.27
Post-treatment 175.00依5.61 172.00依4.07 162.00依6.29 166.00依2.83 178.00依8.86 162依5.91 180.00依7.01 188.00依7.67 192.00依9.71 180.00依7.53 180.00依4.89 193依4.71
2 HB (g%) Pre-treatment 12.80依0.92 13.30依0.45 167.00依7.04 12.70依0.47 10.10依0.91 10.2依0.91 13.70依0.34 12.30依0.84 11.90依0.43 11.40依0.59 12.70依0.19 12.4依0.25
Post-treatment 12.30依0.85 13.30依0.55 12.80依0.27 12.00依0.49 11.40依1.10 11.4依0.58 13.80依0.43 12.20依0.49 11.80依0.26 11.60依0.64 13.20依0.10 12.9依0.27
3 RBCcount(106/毺L) Pre-treatment 6.40依0.30 6.30依0.27 13.00依0.35 7.40依0.29 6.00依0.54 6.3依0.59 7.80依0.64 6.80依0.25 7.30依0.30 7.10依0.55 6.50依0.43 7.9依0.39
Post-treatment 6.40依0.17 6.50依0.27 7.30依0.26 7.40依0.19 6.70依0.64 6.1依0.43 8.15依0.54 7.20依0.17 7.40依0.20 7.60依0.65 6.50依0.31 7.9依0.31
4 WBCcount (103/毺L) Pre-treatment 9.30依0.36 9.00依0.16 7.20依0.17 9.30依0.29 9.75依0.67 9.95依0.5 8.70依0.23 9.12依0.27 9.35依0.30 9.30依0.19 8.40依0.19 8.67依0.22
Post-treatment 8.90依0.27 9.90依0.32 9.10依0.50 9.80依0.35 9.45依0.65 10.78依0.58 9.40依0.24 9.20依0.14 10.80依0.14 10.80依0.32 8.52依0.19 8.87依0.23
5 Urea (mg/dL) Pre-treatment 29.50依1.71 29.50依0.99 9.20依0.39 26.00依2.35 35.80依2.38 36.3依2.31 28.10依1.48 30.50依2.57 28.30依1.39 30.30依0.83 28.30依0.37 8.67依0.22
Post-treatment 34.00依1.27 32.30依0.39 27.00依1.62 30.60依3.29 42.1依2.45 45.7依3.50 32.70依1.17 32.80依2.55 36.30依0.42 36.30依2.16 33.30依1.22 8.87依0.23
6 Creatinine (mg/dL) Pre-treatment 0.80依0.10 1.10依0.20 31.00依1.75 0.70依0.14 0.90依0.11 0.87依0.10 0.70依0.19 0.70依0.18 0.87依0.12 0.95依0.06 0.95依0.06 29.6依0.77
Post-treatment 0.90依0.02 0.80依0.17 0.90依0.08 0.70依0.17 1.50依0.14 1.60依0.18 0.80依0.10 1.10依0.17 1.02依0.04 1.40依0.07 0.90依0.04 28.3依1.42
7 SGOT Pre-treatment 41.10依2.64 39.10依1.11 0.90依0.06 37.70依1.84 39.50依2.19 38.50依1.10 37.60依2.01 36.50依1.36 35.70依2.14 39.70依0.89 39.20依1.57 0.95依0.09
Post-treatment 42.80依2.90 45.70依1.07 46.50依2.34 41.50依1.50 43.70依1.21 42.50依1.48 46.50依2.78 43.50依1.83 44.30依1.87 48.80依1.58 47.70依4.01 1.10依0.17
8 SGPT Pre-treatment 40.50依3.05 32.40依3.07 56.80依3.76 31.20依2.34 34.00依2.37 32.40依1.62 30.00依0.70 33.50依2.44 30.10依0.84 32.40依1.84 24.20依0.89 39.7依1.44
Post-treatment 45.30依2.95 36.30依4.65 34.60依2.18 33.90依1.54 38.20依2.91 34.30依1.98 37.90依1.01 38.50依2.48 37.70依1.66 37.00依2.16 28.80依0.39 42.4依1.76
9 Blood sugar
 (mg%)
Pre-treatment 93.50依2.72 94.50依3.72 36.30依4.38 86.20依3.48 93.00依4.72 97.20依6.04 97.20依4.72 99.50依4.55 95.50依3.29 94.50依2.94 93.70依2.25 23.5依2.16
Post-treatment 90.50依1.89 90.50依2.78 93.20依3.30 82.50依3.40 96.50依5.17 100.50依4.97 95.70依3.47 95.00依3.46 98.00依3.71 98.50依3.79 93.00依1.91 22.7依1.81
90.20依2.65 96.5依4.48
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sub-acute toxicity studies.
3.2 Sub-acute toxicity study
  None of the extract of any of the three plants produced 
any mortality in animals at the MTD administered (Table 
2) over 28 d. No sign of observable toxicity was detected 
during the experimental period. All the haematological 
parameters such as haemoglobin, RBC count, WBC count, 
urea, creatinine level, blood sugar level and biochemical 
parameters such as SGOT, SGPT were determined before 
the start of dosing (pre-treatment) as well as at the end of 
the study (post-treatment) (Table 3). All parameters were 
found within the normal range. These results suggested 
that the selected herbs can be used for treatment of chronic 
diseases without exhibiting any side/toxic effect.
4. Discussion    
  In conclusion, Acute and sub-acute studies on C. 
inerme, J. mesnyi Hance and C. citrinus were carried out 
as a prerequisite to exploration of antidiabetic potential 
of these plants. The LD50 of each of the ethyl acetate, 
chloroform, ethanolic and aqueous extracts of each plant 
was determined and MTD was calculated. Each extract was 
evaluated for its sub-acute toxicity at its MTD and was 
found to be non toxic. The selected plants can be further 
explored for their therapeutic potential in different chronic 
diseases.
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